Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Recruiting 3Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Sentinel Lymph Node Biopsy (SLNB) 1Mouth Neoplasms 1Breast Neoplasms 1

Interventions

Specimen Handling 302Magnetic Resonance Spectroscopy 261pembrolizumab 249Carboplatin 184Cyclophosphamide 175Biopsy 167Cisplatin 157Gemcitabine 134Paclitaxel 130Bevacizumab 123fludarabine 115Nivolumab 108Radiotherapy 107Oxaliplatin 88Docetaxel 87Fluorouracil 85Capecitabine 83venetoclax 78Dexamethasone 76Pemetrexed 72Rituximab 69Leucovorin 69Drug Therapy 69atezolizumab 67durvalumab 66Radiosurgery 65Blood Specimen Collection 64Doxorubicin 63Standard of Care 62Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Sentinel Lymph Node Biopsy × 90 days × Clear all
NCT07579286 2026-05-12

LumiNOde

N.N. Petrov National Medical Research Center of Oncology

Phase NA Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT04333537 2026-05-04

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

NRG Oncology

Phase 2/3 Recruiting
686 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT07508306 2026-04-02

Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity

Faculty of Medicine of Tunis

Recruiting
30 enrolled
Gynecologic

Sentinel Lymph Node Biopsy (SLNB)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡